Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Schroeder

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Molecular Diagnostics : JMD|April 12, 2008
High-throughput homogeneous mass cleave assay technology for the diagnosis of autosomal recessive Parkinson's diseaseChristopher Schroeder, Michael Walter, Daniela Berg, et al.
Plos One|June 23, 2017
Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasiaPerikles Kosmidis, Irina Bonzheim, Claudia Dufke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2018
Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapyKerstin Zwirner, Franz J Hilke, German Demidov, et al.
Radiology and Oncology|June 26, 2026
Weekly measurement of HMGB1 during neoadjuvant chemoradiotherapy in rectal cancer patients: correlations with MRI response and ctDNAFranziska Eckert, Vlatko Potkrajcic, Stephan Clasen, et al.
Clinical and Translational Radiation Oncology|May 1, 2025
Rectal stenosis after immunotherapy in a mismatch repair deficient rectal cancer. Case report and review of literatureMarcel Büttner, Ulrike Schempf, Robert Bachmann, et al.
Clinical and Translational Radiation Oncology|December 13, 2024
Tumor sequencing before and after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: Genetic tumor characterization and clinical outcomeKerstin Clasen, Nadja Ballin, Leon Schütz, et al.
Molecular Genetics & Genomic Medicine|September 7, 2021
Detection of mobile elements insertions for routine clinical diagnostics in targeted sequencing dataGerman Demidov, Joohyun Park, Sorin Armeanu-Ebinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 21, 2020
Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapyFranz J Hilke, Francesc Muyas, Jakob Admard, et al.
Radiation Oncology (London, England)|November 7, 2024
Dynamics of cell-free tumor DNA correlate with early MRI response during chemoradiotherapy in rectal cancerKerstin Clasen, Cihan Gani, Leon Schuetz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 25, 2019
Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2DKerstin Zwirner, Franz J Hilke, German Demidov, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Molecular Diagnostics : JMD|April 12, 2008
High-throughput homogeneous mass cleave assay technology for the diagnosis of autosomal recessive Parkinson's diseaseChristopher Schroeder, Michael Walter, Daniela Berg, et al.
Plos One|June 23, 2017
Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasiaPerikles Kosmidis, Irina Bonzheim, Claudia Dufke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2018
Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapyKerstin Zwirner, Franz J Hilke, German Demidov, et al.
Radiology and Oncology|June 26, 2026
Weekly measurement of HMGB1 during neoadjuvant chemoradiotherapy in rectal cancer patients: correlations with MRI response and ctDNAFranziska Eckert, Vlatko Potkrajcic, Stephan Clasen, et al.
Clinical and Translational Radiation Oncology|May 1, 2025
Rectal stenosis after immunotherapy in a mismatch repair deficient rectal cancer. Case report and review of literatureMarcel Büttner, Ulrike Schempf, Robert Bachmann, et al.
Clinical and Translational Radiation Oncology|December 13, 2024
Tumor sequencing before and after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: Genetic tumor characterization and clinical outcomeKerstin Clasen, Nadja Ballin, Leon Schütz, et al.
Molecular Genetics & Genomic Medicine|September 7, 2021
Detection of mobile elements insertions for routine clinical diagnostics in targeted sequencing dataGerman Demidov, Joohyun Park, Sorin Armeanu-Ebinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 21, 2020
Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapyFranz J Hilke, Francesc Muyas, Jakob Admard, et al.
Radiation Oncology (London, England)|November 7, 2024
Dynamics of cell-free tumor DNA correlate with early MRI response during chemoradiotherapy in rectal cancerKerstin Clasen, Cihan Gani, Leon Schuetz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 25, 2019
Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2DKerstin Zwirner, Franz J Hilke, German Demidov, et al.
Pageof 8